-
Despite existing national recommendations to the contrary, more than a third of hospitals reporting performance measurement data to The Joint Commission are not offering pneumococcal vaccine to their pneumonia patients, a recent report reveals.
-
The Joint Commission has created some Q&A clarification of its standards regarding tissue handling and transplantation in light of some highly publicized incidents of inappropriate practices.
-
A prospective randomized, placebo-controlled, multi-center trial demonstrates that a prolonged course of intravenous selenium improves mortality in patients with severe sepsis and septic shock and is associated with minimal to no side effects.
-
The incidence of invasive infections due to MRSA in 2005 was approximately 100 times greater in chronic dialysis patients than in the general population.
-
Since the publication of the initial IDSA Guidelines for the Management of Community-Acquired Pneumonia in 2003, hospital administrators have been scrambling to improve their numbers.
-
Unfractionated heparin (UH) is commonly used in acutely ill hospital patients at risk for venous thromboembolism (VTE).
-
Among 413 patients who underwent placement of a removable inferior vena cava filter following trauma for prophylaxis or treatment of pulmonary thromboembolism and survived to hospital discharge, subsequent removal of the filter was attempted in 116 of them and successful in only 91 (22%).
-
IVIG is safe and effective for worsening Myasthenia Gravis, but has no effect on the natural course of Miller Fisher syndrome.
-
-
This pilot study from the Medical and Coronary ICUs at Vanderbilt University Medical Center sought to identify factors associated with the development of symptoms of post-traumatic stress disorder (PTSD) following critical illness.
